PMA P030023S004

Device
CAPSULAR TENSION RING AND STABILEYES
Applicant
Ophtec BV
PMA number
P030023
Supplement
S004
Product code
MRJ
Decision date
2015-11-13
Classification
Ring, Endocapsular
Generic name
Ring, endocapsular
Approval order statement
APPROVAL TO INCLUDE THE RINGJECT, A DISPOSABLE INJECTOR/DELIVERY SYSTEM DESIGNED FOR USE WITH CAPSULAR TENSION RINGS (CTRS), ADDITION OF THE INJECTOR INTO THE SAME STERILE PACKAGING PROCESS AS THE CTR AND MODIFICATION OF THE PACKAGING CONFIGURATION TO ACCOMMODATE THE COMBINED INJECTOR AND THE PRELOADED CTR. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME RINGJECT, MODEL 375 AND MODEL 376. CTRS ARE INDICATED FOR THE STABILIZATION OF WEAKENED, BROKEN, OR MISSING ZONULES THAT ARE SUSPECTED OR OBSERVED DURING CATARACT EXTRACTION USING PHACOEMULSIFICATION AND CONTINUOUS CURBILINEAR CAPSULORHEXIS TECHNIQUES IN ADULTS.

Current openFDA PMA Record#

Device
CAPSULAR TENSION RING AND STABILEYES
Applicant
Ophtec BV
PMA number
P030023
Supplement
S004
Product code
MRJ
Generic name
Ring, endocapsular
Decision date
2015-11-13
Decision code
APPR
Date received
2014-07-21
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL TO INCLUDE THE RINGJECT, A DISPOSABLE INJECTOR/DELIVERY SYSTEM DESIGNED FOR USE WITH CAPSULAR TENSION RINGS (CTRS), ADDITION OF THE INJECTOR INTO THE SAME STERILE PACKAGING PROCESS AS THE CTR AND MODIFICATION OF THE PACKAGING CONFIGURATION TO ACCOMMODATE THE COMBINED INJECTOR AND THE PRELOADED CTR. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME RINGJECT, MODEL 375 AND MODEL 376. CTRS ARE INDICATED FOR THE STABILIZATION OF WEAKENED, BROKEN, OR MISSING ZONULES THAT ARE SUSPECTED OR OBSERVED DURING CATARACT EXTRACTION USING PHACOEMULSIFICATION AND CONTINUOUS CURBILINEAR CAPSULORHEXIS TECHNIQUES IN ADULTS.